Hepatectomy
================
Oscar J. Ponce & Eddy Lincango
18/11/2020

## Figure 2: Continuous Outcomes Part 1

![](hepatectomy_files/figure-gfm/overall_continuous_donor1-1.svg)<!-- -->

**Supplementary information for figure 1**

<details>

<summary>Suppl. figure 1: Mean total operative time (min) after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/operativetime1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 2: Mean total operative time (min) after RLDRH vs
ODRH</summary>

![](hepatectomy_files/figure-gfm/operativetime2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 3: Mean blood loss (mL) after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/blood_loss_1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 4: Mean blood loss (mL) after RLDRH versus ODRH
</summary>

<img src="hepatectomy_files/figure-gfm/blood_loss2-1.svg" width="14400" />

</details>

<details>

<summary>Suppl. figure 5: Mean peak ALT levels (IU/L) after RLDRH versus
LADRH</summary>

![](hepatectomy_files/figure-gfm/alt1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 6: Mean peak ALT levels (IU/L) after RLDRH versus
ODRH</summary>

![](hepatectomy_files/figure-gfm/alt2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 7: Mean peak AST levels (IU/L) after RLDRH versus
LADRH</summary>

![](hepatectomy_files/figure-gfm/ast1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 8: Mean peak AST levels (IU/L) after RLDRH versus
ODRH</summary>

![](hepatectomy_files/figure-gfm/ast2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 9: Mean blood loss (mL) after RLDRH versus
ODRH</summary>

![](hepatectomy_files/figure-gfm/blood_ODRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 10: Mean ALT peak levels (IU/L) after RLDRH
versus ODRH</summary>

![](hepatectomy_files/figure-gfm/alt_ODRH_recipient-1.svg)<!-- -->

</details>

## Figure 3: Continuous Outcomes Part 2

![](hepatectomy_files/figure-gfm/overall_continuous2-1.svg)<!-- -->

**Supplementary information for figure 3**

<details>

<summary>Suppl. figure 11: Mean peak total bilirubin levels (mg/dL)
after RLDRH vs LADRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 12: Mean peak total bilirubin levels (mg/dL)
after RLDRH vs ODRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 13: Mean pain scores (VAS) after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/pain2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 14: Mean pain scores (VAS) at day 0-1 after RLDRH
vs ODRH</summary>

![](hepatectomy_files/figure-gfm/pain2_followup1-1.svg)<!-- -->

</p>

</details>

<details>

<summary>Suppl. figure 15: Mean pain scores (VAS) at day 2-3 after RLDRH
vs ODRH</summary>

<p>

![](hepatectomy_files/figure-gfm/pain2_followup2-1.svg)<!-- -->

</p>

</details>

<details>

<summary>Suppl. figure 16: Mean pain scores (VAS) at day \>3 after RLDRH
vs ODRH</summary>

<p>

![](hepatectomy_files/figure-gfm/pain2_followup3-1.svg)<!-- -->

</p>

</details>

<details>

<summary>Suppl. figure 17: Mean length of hospital stay (days) after
RLDRH vs LADRH</summary>

![](hepatectomy_files/figure-gfm/hospital1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 18: Mean length of hospital stay (days) after
RLDRH vs ODRH</summary>

![](hepatectomy_files/figure-gfm/hospital2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 19: Mean AST peak levels (U/L) after RLDRH vs
ODRH</summary>

![](hepatectomy_files/figure-gfm/ast_ODRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 20: Mean peak total bilirubin levels after RLDRH
vs ODRH</summary>

![](hepatectomy_files/figure-gfm/bilirubin_ODRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 21: Mean length of hospital stay (days) after
RLDRH vs LADRH</summary>

![](hepatectomy_files/figure-gfm/hospitalstay_LADRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 22: Mean length of hospital stay (days) after
RLDRH vs ODRH</summary>

![](hepatectomy_files/figure-gfm/hospitalstay_ODRH_recipient-1.svg)<!-- -->

</details>

# Figure 4: Dichotomous outcomes

![](hepatectomy_files/figure-gfm/overall_dichotomous-1.svg)<!-- -->

**Supplementary information for figure 4**

<details>

<summary>Suppl. figure 23: Mortality risk at 30 days after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/mortality_LADRH-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 24: Mortality risk at 30 days after RLDRH vs
ODRH</summary>

![](hepatectomy_files/figure-gfm/mortality_ODRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 25: Clevien-Dindo I-II at 30 days after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/LADRH_complication1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 26: Clevien-Dindo complications I-II at 30 days
after RLDRH vs ODRH</summary>

![](hepatectomy_files/figure-gfm/ODRH_complication1-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 27: Clevien-Dindo III-IV at 30 days after RLDRH
vs LADRH</summary>

![](hepatectomy_files/figure-gfm/LADRH_complication2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 28: Clevien-Dindo III-IV at 30 days after RLDRH
vs ODRH</summary>

![](hepatectomy_files/figure-gfm/ODRH_complication2-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 29: Clevien-Dindo I-II at 30 days after RLDRH vs
LADRH</summary>

![](hepatectomy_files/figure-gfm/complciationsI_LADRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 30: Clevien-Dindo I-II at 30 days after RLDRH vs
ODRH</summary>

![](hepatectomy_files/figure-gfm/complicationsI_ODRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 31: Clevien-Dindo III-IV at 30 days after RLDRH
VS LADRH</summary>

![](hepatectomy_files/figure-gfm/complicationsIII_LADRH_recipient-1.svg)<!-- -->

</details>

<details>

<summary>Suppl. figure 32: Clevien-Dindo III-IV at 30 days after RLDRH
vs ODRH</summary>

![](hepatectomy_files/figure-gfm/complicationsIII_ODRH_recipient-1.svg)<!-- -->

</details>
